Today's
date
Jergen Biotech
123 Biotech Lane
Any town, Any state 12345
CONTACT
PERSON: Connie Pressperson, 555-1234
REF: Jergen Biotech to acquire
BioSolutions
Jergen Biotech announced today that they have signed
a merger agreement to acquire BioSolutions. BioSolutions is a manufacturer
of instruments for invasive surgeries.
Jergen Biotech will acquire
BioSolutions for half a million shares of common stock. The stock is valued
at $65 million.
"The merger of our two companies will present a large,
beneficial presence," says Charles Smith. He is CEO and president of Jergen
Biotech.
BioSolutions' president Thomas Brown will join the Jergen
Biotech management team immediately following the merger. "As we merge with
Jergen, we will be in a position to increase our presence in the current market,"
says Brown.
The merger is subject to regulatory approval. Upon approval,
the merger will be completed within 90 days.
For more information,
please contact Connie Pressperson at 555-1234.